secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K/A
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001641172-25-025396
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 9.01, 1.01, 2.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos closes Sleep Center of Nevada acquisition for $6M cash + stock; issues $8.25M note
--------------------------------------------------------------------------------

- Acquired operating assets of SCN for $6M cash, 607k restricted shares ($1.5M at VWAP), plus contingent earn-out of up to $1.5M in stock.
- Wholly-owned AIM subsidiary signed 15-year PAAs with SCN ($200k/mo fee) and SCN PLLC ($100k/mo fee) to manage practice in compliance with CPM laws.
- Issued $8.25M secured promissory note to Streeterville Capital to finance the acquisition; AIM membership interests pledged as collateral.
- Integration of two of seven SCN locations underway; deploying 1.5 SO teams currently, targeting 4.5 teams by Q1 2026; patient demand exceeds capacity.
- SCN revenue expected in Q2 fiscal 2025; risk factors note unproven model, CPM law compliance, and debt service obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225025396/0001641172-25-025396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225025396/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-025396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer